Trade

Global Health share price

Balanced risk
  • 30%Low risk
  • 30%Moderate risk
  • 30%Balanced risk
  • 30%High risk
  • 30%Extreme risk
  • 1,111.40(0.11%)
    March 5, 2026 15:29:02 PM IST
    • NSE
    • BSE
  • Vol : 76.66 K (NSE + BSE)
    Last 20 day avg : 184.83 K

Global Health is trading 0.11% upper at Rs 1,111.40 as compared to its last closing price. Global Health has been trading in the price range of 1,118.80 & 1,095.75. Global Health has given -6.46% in this year & -3.50% in the last 5 days. Global Health has TTM P/E ratio 62.01 as compared to the sector P/E of 25.23.There are 11 analysts who have initiated coverage on Global Health. There are 4 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 95.02 Crores in its last quarter.Listed peers of Global Health include Max Healthcare Institute (0.35%), Apollo Hospitals Enterprise (1.43%), Narayana Hrudayalaya (1.62%).The Mutual Fund holding in Global Health was at 13.12% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Global Health was at 10.54% in 31 Dec 2025. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Mar 06, 2026, 12:02 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.02
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.21
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.05
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    1.67
    Indicates Fair Valuation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
1,095.75
Highest
1,118.80
52 week range
Lowest
1,015.00
Highest
1,455.85
Global Health Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Max Healthcare Institute
Bearish
1,057.400.351,02,982.8093.4311.210.1429.50
Apollo Hospitals Enterprise
Bullish
7,775.851.431,11,804.7971.0912.560.2683.18
Narayana Hrudayalaya
Bearish
1,768.451.6236,140.1947.6610.510.2459.03
Fortis Healthcare
Neutral
920.851.1369,520.3280.047.640.1125.92
Aster DM Healthcare
Bullish
658.451.3734,115.6886.958.680.8453.36
Mutual Fund Ownership
View all
Invesco India Focused Fund Regular Growth
5/5
  • Amount Invested (Cr.) 162.57
  • % of AUM 4.08
HSBC Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 45.67
  • % of AUM 3.01
PGIM India Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 3.15
  • % of AUM 2.89
Invesco India Smallcap Fund Regular Growth
3/5
  • Amount Invested (Cr.) 182.81
  • % of AUM 2.68
Invesco India Mid Cap Fund Growth
4/5
  • Amount Invested (Cr.) 170.37
  • % of AUM 2.57
Global Health Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-02-04Quarterly Results
2025-11-07Quarterly Results
2025-08-07Quarterly Results
2025-05-15Audited Results & Final Dividend
2025-02-04Quarterly Results
About the company Global Health
  • IndustryHealthcare Facilities
  • ISININE474Q01031
  • BSE Code543654
  • NSE CodeMEDANTA
Global Health Limited (Medanta) is an India-based multi-specialty tertiary care provider in the North and East regions of India. Medanta delivers advanced, end-to-end healthcare in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow through its network of approximately five hospitals. Medanta provides healthcare services in over 30 medical specialties and engages over 1,800 doctors. Its specialty treatments are in cardiac care, cancer care, neurosciences, orthopedics, renal care, liver transplants, oncology, bone marrow transplant, obstetrics and gynecology, chest surgery, lung transplant, pediatric care, ENT, head and neck surgery, and others. Its facilities and services include medicine delivery, lab tests & diagnostics, homecare services, health checkups, elder care, air ambulance, among others. Its subsidiaries include Global Health Patliputra Private Limited, Medanta Holdings Private Limited, and GHL Pharma & Diagnostic Private Limited.
  • Management Info
  • Naresh TrehanChairman of the Board, Managing Director
  • Pankaj SahniGroup Chief Executive Officer, Whole Time Director
  • Yogesh GuptaChief Financial Officer
  • Manoj GuptaSenior Vice President, Head - Human Resources
  • Saurabh UpadhyaySenior Vice President, Head of Human Resources
  • Rajiv SikkaChief Information Officer
  • Rahul RanjanCompliance Officer, Company Secretary
  • Richa SinghGeneral Counsel
  • Sanjay GeedMedical Director - Indore Hospital/Unit
  • Sanjeev GuptaMedical Director - Medical Administration and Clinical Operations at Medanta - the Medicity, Gurugram
Global Health Share Price FAQs

Global Health is trading at 1111.40 as on Thu Mar 05 2026 09:59:02. This is 0.11% upper as compared to its previous closing price of 1110.15.

The market capitalization of Global Health is 30011.23 Cr as on Thu Mar 05 2026 09:59:02.

The average broker rating on Global Health is Buy. The breakup of analyst rating is given below -

  • 4 analysts have given a strong buy rating
  • 2 analysts have given a buy rating
  • 4 analysts have given a hold rating
  • 1 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Global Health is 1455.85 whereas the 52 wk low is 1015.00

Global Health can be analyzed on the following key metrics -

  • TTM P/E: 62.01
  • Sector P/E: 25.23
  • Dividend Yield: 0.05%
  • D/E ratio: -

Global Health reported a net profit of 481.44 Cr in 2025.

The Mutual Fund Shareholding was 13.12% at the end of 31 Dec 2025.